Chen and colleagues conducted a separate analysis of the PVTT group and found that the use of ICI resulted in a remarkable HR of 0.15 ( 14 ), indicating a highly significant effect.
← all excerpts
Postoperative adjuvant immunotherapy for high-risk hepatocellular carcinoma patients.
1
—
—